Odomzo User Reviews & Ratings
Odomzo has an average rating of 8.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Basal Cell Carcinoma | 1 reviews for Basal Cell Carcinoma | 7 medications | |
Add your review |
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Odomzo (sonidegib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español
For Basal Cell Carcinoma "Took Odomzo for nine months. Worked very well. My oncologist was actually amazed. Tumor vanished. The side effects were more than I was prepared for, based on what I was told and what I had read. Bone and muscle pain, often debilitating muscle cramps, and fatigue. In all fairness to the drug, I did have unrelated major surgery during this period ( colectomy/ colostomy take down). I would choose the Odomzo option over surgery if faced with the same situation. In my case surgery would have come with ballooning, skin grafts, on pre existing scar tissue."